· 9/19/2002
Novo Nordisk A/s, Novo Nordisk of North America, Inc., and Novo Nordisk Pharmaceuticals, Inc. v. Becton Dickinson and Company, Defendant-Cross
Citations
- 304 F.3d 1216
- 64 U.S.P.Q. 2d (BNA) 1524
- 2002 U.S. App. LEXIS 19287
- 2002 WL 31084942
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- “[C]ounsel . . . cannot as a rule remain silent, interpose no objections, and after a verdict has been returned seize for the first time on the point that the comments to the jury were prejudicial.” (citation omitted)
Source: CourtListener parenthetical corpus (CC0).
Judges: Newman, Schall, Bryson
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.